
Lynparza 150 mg (Olaparib)
150mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Olaparib is used as an anticancer drug that inhibits the growth of certain cancer cells.
MFDS ingredient code M262546
Olaparib is an anticancer agent that inhibits the PARP enzyme and is primarily used in the treatment of cancer cells with genetic defects. This ingredient blocks enzymes that repair DNA damage, making it difficult for cancer cells to survive.
Olaparib inhibits the PARP enzyme responsible for DNA repair within cancer cells, preventing damaged DNA from being properly repaired. As a result, it induces cancer cells to undergo apoptosis, thereby blocking tumor growth.
Approved uses differ by product. Check each product's information for its actual use.
Olaparib is one of the PARP inhibitors and is particularly effective against cancers with BRCA gene mutations. Unlike other anticancer drugs, it selectively targets the DNA repair pathway to attack cancer cells.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
3 total

150mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

100mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
50mg
Hard capsule · Prescription medication
AstraZeneca Korea Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.